vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and RED RIVER BANCSHARES INC (RRBI). Click either name above to swap in a different company.
RED RIVER BANCSHARES INC is the larger business by last-quarter revenue ($33.2M vs $24.8M, roughly 1.3× Ceribell, Inc.). RED RIVER BANCSHARES INC runs the higher net margin — 34.4% vs -54.6%, a 89.0% gap on every dollar of revenue. RED RIVER BANCSHARES INC produced more free cash flow last quarter ($42.2M vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Red River Bancshares Inc is a U.S. regional financial holding company operating through its wholly owned subsidiary Red River Bank. It provides a full suite of retail and commercial banking products including deposit accounts, personal and commercial loans, mortgage services, and wealth management, primarily serving customers across Louisiana, with a focus on local communities and small to mid-sized enterprises.
CBLL vs RRBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $33.2M |
| Net Profit | $-13.5M | $11.4M |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | 42.8% |
| Net Margin | -54.6% | 34.4% |
| Revenue YoY | — | 15.7% |
| Net Profit YoY | — | 22.7% |
| EPS (diluted) | $-0.35 | $1.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $33.2M | ||
| Q3 25 | $22.6M | $31.9M | ||
| Q2 25 | $21.2M | $30.5M | ||
| Q1 25 | $20.5M | $29.9M | ||
| Q4 24 | — | $28.7M | ||
| Q3 24 | $17.2M | $27.9M | ||
| Q2 24 | — | $26.9M | ||
| Q1 24 | — | $26.3M |
| Q4 25 | $-13.5M | $11.4M | ||
| Q3 25 | $-13.5M | $10.8M | ||
| Q2 25 | $-13.6M | $10.2M | ||
| Q1 25 | $-12.8M | $10.4M | ||
| Q4 24 | — | $9.3M | ||
| Q3 24 | $-10.4M | $8.8M | ||
| Q2 24 | — | $8.0M | ||
| Q1 24 | — | $8.2M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | 42.8% | ||
| Q3 25 | -64.8% | 41.9% | ||
| Q2 25 | -70.5% | 41.7% | ||
| Q1 25 | -69.3% | 43.0% | ||
| Q4 24 | — | 40.2% | ||
| Q3 24 | -57.8% | 38.8% | ||
| Q2 24 | — | 36.8% | ||
| Q1 24 | — | 38.5% |
| Q4 25 | -54.6% | 34.4% | ||
| Q3 25 | -59.6% | 33.8% | ||
| Q2 25 | -64.4% | 33.4% | ||
| Q1 25 | -62.4% | 34.6% | ||
| Q4 24 | — | 32.4% | ||
| Q3 24 | -60.6% | 31.4% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 31.1% |
| Q4 25 | $-0.35 | $1.72 | ||
| Q3 25 | $-0.37 | $1.63 | ||
| Q2 25 | $-0.38 | $1.51 | ||
| Q1 25 | $-0.36 | $1.52 | ||
| Q4 24 | — | $1.36 | ||
| Q3 24 | $-1.85 | $1.27 | ||
| Q2 24 | — | $1.16 | ||
| Q1 24 | — | $1.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $213.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $365.1M |
| Total Assets | $195.8M | $3.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $213.4M | ||
| Q3 25 | $168.5M | $161.1M | ||
| Q2 25 | $177.4M | $210.4M | ||
| Q1 25 | $182.7M | $252.2M | ||
| Q4 24 | — | $269.0M | ||
| Q3 24 | $14.1M | $232.6M | ||
| Q2 24 | — | $213.1M | ||
| Q1 24 | — | $229.8M |
| Q4 25 | $155.3M | $365.1M | ||
| Q3 25 | $164.1M | $351.3M | ||
| Q2 25 | $172.2M | $335.4M | ||
| Q1 25 | $180.9M | $333.3M | ||
| Q4 24 | — | $319.7M | ||
| Q3 24 | $-136.0M | $324.3M | ||
| Q2 24 | — | $307.0M | ||
| Q1 24 | — | $299.3M |
| Q4 25 | $195.8M | $3.4B | ||
| Q3 25 | $199.5M | $3.2B | ||
| Q2 25 | $207.7M | $3.2B | ||
| Q1 25 | $213.5M | $3.2B | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | $47.1M | $3.1B | ||
| Q2 24 | — | $3.0B | ||
| Q1 24 | — | $3.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $44.8M |
| Free Cash FlowOCF − Capex | $-11.0M | $42.2M |
| FCF MarginFCF / Revenue | -44.2% | 127.2% |
| Capex IntensityCapex / Revenue | 0.7% | 7.8% |
| Cash ConversionOCF / Net Profit | — | 3.92× |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | $75.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $44.8M | ||
| Q3 25 | $-11.1M | $16.5M | ||
| Q2 25 | $-7.5M | $3.8M | ||
| Q1 25 | $-11.4M | $13.9M | ||
| Q4 24 | — | $38.3M | ||
| Q3 24 | — | $17.4M | ||
| Q2 24 | — | $2.4M | ||
| Q1 24 | — | $14.4M |
| Q4 25 | $-11.0M | $42.2M | ||
| Q3 25 | $-11.5M | $15.8M | ||
| Q2 25 | $-7.6M | $3.5M | ||
| Q1 25 | $-11.6M | $13.7M | ||
| Q4 24 | — | $33.4M | ||
| Q3 24 | — | $17.0M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $13.4M |
| Q4 25 | -44.2% | 127.2% | ||
| Q3 25 | -50.8% | 49.6% | ||
| Q2 25 | -35.9% | 11.6% | ||
| Q1 25 | -56.4% | 45.7% | ||
| Q4 24 | — | 116.5% | ||
| Q3 24 | — | 60.9% | ||
| Q2 24 | — | 5.4% | ||
| Q1 24 | — | 50.8% |
| Q4 25 | 0.7% | 7.8% | ||
| Q3 25 | 1.6% | 2.1% | ||
| Q2 25 | 0.3% | 0.9% | ||
| Q1 25 | 0.7% | 0.9% | ||
| Q4 24 | — | 17.0% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 3.6% | ||
| Q1 24 | — | 4.0% |
| Q4 25 | — | 3.92× | ||
| Q3 25 | — | 1.53× | ||
| Q2 25 | — | 0.37× | ||
| Q1 25 | — | 1.34× | ||
| Q4 24 | — | 4.11× | ||
| Q3 24 | — | 1.99× | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
RRBI
Segment breakdown not available.
